1. Kranjčević, K. Adrenocortical carcinoma. Acta Med Croatica 2016; 70(4–5): 315–318.
Google Scholar | Medline2. Papathomas, TG, Pucci, E, Giordano, TJ, et al. An international Ki67 reproducibility study in adrenal cortical carcinoma. Am J Surg Pathol 2016; 40(4): 569–576.
Google Scholar | Crossref | Medline3. Leteurtre, E, Al Ghuzlan, A, Patey, M, et al. Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy. Am J Surg Pathol 2012; 36(8): 1194–1201.
Google Scholar | Crossref | Medline4. Wang, TS, Rossfeld, KK, Maithel, SK, et al. The prognostic significance of adrenocortical carcinomas identified incidentally. J Surg Oncol 2018; 118(7): 1155–1162.
Google Scholar | Crossref | Medline5. Mishra, A, Kapoor, S, Agarwal, A, et al. Weiss criteria in large adrenocortical tumors: a validation study. Indian J Pathol Microbiol 2010; 53(2): 222.
Google Scholar | Crossref | Medline6. Nowak, KM, Samsel, R, Cichocki, A, et al. Prognostic factors in adrenocortical carcinoma: data from a large Polish series. Polish Arch Intern Med 2018; 128(6): 371–378.
Google Scholar | Medline7. Mohan, DR, Lerario, AM, Hammer, GD. Therapeutic targets for adrenocortical carcinoma in the genomics era. J Endocr Soc 2018; 2: 1259–1274.
Google Scholar | Crossref | Medline8. Erickson, LA. Challenges in surgical pathology of adrenocortical tumours. Histopathology 2018; 72(1): 82–96.
Google Scholar | Crossref | Medline9. Allolio, B, Hahner, S, Weismann, D, et al. Management of adrenocortical carcinoma. J Natl Compr Canc Netw 2009; 7(7): 752–759.
Google Scholar | Crossref | Medline10. Pereira, MA, Arap, S, Mendonça, BB, et al. Adrenocortical tumors: results of treatment and study of Weiss’s score as a prognostic factor. Rev Hosp Clin Fac Med Sao Paulo 2005; 57(6): 251–256.
Google Scholar11. Berruti, A, Baudin, E, Gelderblom, H, et al. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23: 131–138.
Google Scholar | Crossref12. Libé, R. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Front Cell Dev Biol 2015; 3: 45.
Google Scholar | Crossref | Medline13. Lloyd, RV, Osamura, YR, Kloppel, G, et al. WHO classification of tumours of endocrine organs. IARC Publications, WHO Press, 2017.
Google Scholar14. Fassnacht, M, Dekkers, OM, Else, T, et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol 2018; 179: G1–G46.
Google Scholar | Crossref | Medline15. Johnson, SJ, Royal, V, Infirmary, N, et al. Standards and datasets for reporting cancers cancer dataset for the histological reporting of adrenal cortical carcinoma and phaeochromocytoma/paraganglioma. 2nd ed. www.nice.org.uk/accreditation (2012, accessed 2 May 2020).
Google Scholar16. Duregon, E, Cappellesso, R, Maffeis, V, et al. Validation of the prognostic role of the “Helsinki Score” in 225 cases of adrenocortical carcinoma. Hum Pathol 2017; 62: 1–7.
Google Scholar | Crossref | Medline17. Aubert, S, Wacrenier, A, Leroy, X, et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 2002; 26(12): 1612–1619.
Google Scholar | Crossref | Medline18. Papotti, M, Libè, R, Duregon, E, et al. The Weiss score and beyond-histopathology for adrenocortical carcinoma. Horm Cancer 2011; 2: 333–340.
Google Scholar | Crossref | Medline19. Scollo, C, Russo, M, Trovato, MA, et al. Prognostic factors for adrenocortical carcinoma outcomes. Front Endocrinol 2016; 7: 99.
Google Scholar | Crossref | Medline20. Volante, M, Bollito, E, Sperone, P, et al. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology 2009; 55(5): 535–543.
Google Scholar | Crossref | Medline21. Pennanen, M, Heiskanen, I, Sane, T, et al. Helsinki score – A novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol 2015; 46(3): 404–410.
Google Scholar | Crossref | Medline22. Reid, MD, Bagci, P, Ohike, N, et al. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol 2015; 28(5): 686–694.
Google Scholar | Crossref | Medline23. Lughezzani, G, Sun, M, Perrotte, P, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer 2010; 46: 713–719.
Google Scholar | Crossref | Medline24. Tella, SH, Kommalapati, A, Yaturu, S, et al. Predictors of survival in adrenocortical carcinoma: an analysis from the national cancer database. J Clin Endocrinol Metab 2018; 103: 3566–3573.
Google Scholar | Crossref | Medline25. Souteiro, P, Donato, S, Costa, C, et al. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study. Hormones 2020; 19: 197–203.
Google Scholar | Crossref | Medline26. Sisman, P, Sahin, AB, Peynirci, H, et al. Adrenocortical carcinoma: single center experience. Turk J Urol 2017; 43: 462–469.
Google Scholar | Crossref | Medline27. de Freitas, ACT . Carcinoma da glândula supra-renal. ABCD Arq Bras Cir Dig (São Paulo) 2007; 20(3): 195–200.
Google Scholar | Crossref28. Volante, M, Bollito, E, Sperone, P, et al. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology 2009; 55(5): 535–543.
Google Scholar | Crossref | Medline29. Demeure, MJ, Bussey, KJ, Kirschner, LS. Targeted therapies for adrenocortical carcinoma: IGF and beyond. Horm Cancer 2011; 2: 385–392.
Google Scholar | Crossref | Medline30. Barlaskar, FM, Spalding, AC, Heaton, JH, et al. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metab 2009; 94: 204–212.
Google Scholar | Crossref | Medline31. Guillaud-Bataille, M, Ragazzon, B, De Reyniès, A, et al. IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma. PLoS One 2014; 9: e103744.
Google Scholar | Crossref | Medline32. Giordano, TJ, Kuick, R, Else, T, et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 2009; 15: 668–676.
Google Scholar | Crossref | Medline | ISI33. Pereira, SS, Monteiro, MP, Bourdeau, I, et al. Mechanisms of endocrinology: cell cycle regulation in adrenocortical carcinoma. Eur J Endocrinol 2018; 179: R95–R110.
Google Scholar | Crossref | Medline34. Assié, G, Jouinot, A, Fassnacht, M, et al. Value of molecular classification for prognostic assessment of adrenocortical carcinoma. JAMA Oncol 2019; 5: 1440–1447.
Google Scholar | Crossref | Medline35. Xing, Z, Luo, Z, Yang, H, et al. Screening and identification of key biomarkers in adrenocortical carcinoma based on bioinformatics analysis. Oncol Lett 2019; 18: 4667–4676.
Google Scholar | Medline36. Pereira, SS, Monteiro, MP, Costa, MM, et al. IGF2 role in adrenocortical carcinoma biology. Endocrine 2019; 66(2): 326–337.
Google Scholar | Crossref | Medline37. Wanis, KN, Kanthan, R. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. World J Surg Oncol 2015; 13: 117.
Google Scholar | Crossref | Medline38. Guntiboina, VA, Sengupta, M, Islam, N, et al. Diagnostic and prognostic utility of SF1, IGF2 and p57 immunoexpression in pediatric adrenal cortical tumors. J Pediatr Surg 2019; 54: 1906–1912.
Google Scholar | Crossref | Medline39. Enriquez, ML, Lal, P, Ziober, A, et al. The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms. Appl Immunohistochem Mol Morphol 2012; 20: 141–145.
Google Scholar | Crossref | Medline40. Nunes, JM. Adrenocortical carcinoma – a 25 years tertiary centre experience and short review of the literature. Endocrinol Int J 2018; 6(1): 15–19.
Google Scholar